Articles

Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia

The Ohio State University, Comprehensive Cancer Center, Columbus, OH; Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York
The Ohio State University, Department of Biomedical Informatics, Columbus
The Ohio State University, Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH; Alliance Statistics and Data Center, The Ohio State University, Comprehensive Cancer Center, Columbus
The Ohio State University, Comprehensive Cancer Center, Columbus
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Munich
The Ohio State University, Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus
Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany; Medical Data Integration Center (MeDIC), University Hospital, LMU Munich
Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig
The Ohio State University, Department of Biomedical Informatics, Columbus
Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara
The Ohio State University, Comprehensive Cancer Center, Columbus
The Ohio State University, Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH; Alliance Statistics and Data Center, The Ohio State University, Comprehensive Cancer Center, Columbus
The Ohio State University, Department of Biomedical Informatics, Columbus
The Ohio State University, Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg
The Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC
The Ohio State University, Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus
Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
Roswell Park Comprehensive Cancer Center, Buffalo
Monter Cancer Center, Hofstra Northwell School of Medicine, Lake Success
Dana-Farber Cancer Institute, Harvard University, Boston, MA
Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg
The Ohio State University, Comprehensive Cancer Center, Columbus, OH; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus
The Ohio State University, Comprehensive Cancer Center, Columbus
The Ohio State University, Comprehensive Cancer Center, Columbus
Haematologica Early view Jul 15, 2021 https://doi.org/10.3324/haematol.2021.266643